Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - October 2020

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines.

Budesonide orodispersible (Jorveza®) has been accepted for restricted use in the treatment of eosinophilic oesophagitis (EoE) in adults (older than 18 years of age). The restriction limits use to patients unsuccessfully treated with proton pump inhibitors.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - October 2020' on Email Share 'SMC Update - October 2020' on Delicious Share 'SMC Update - October 2020' on Digg Share 'SMC Update - October 2020' on Facebook Share 'SMC Update - October 2020' on reddit Share 'SMC Update - October 2020' on Twitter

atomic-wealth

No Comments to “SMC Update - October 2020”

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer